Skip to content

Application of 18F-FAPI PET/CT and PET/MR Imaging in the diagnosis and treatment of various malignant tumors

Application of 18F-FAPI PET/CT and PET/MR Imaging in the diagnosis and treatment of various malignant tumors

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400093756
Enrollment
Unknown
Registered
2024-12-11
Start date
2024-12-11
Completion date
Unknown
Last updated
2024-12-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Malignant tumors

Interventions

Gold Standard:Pathologic biopsy is used as the gold standard for the diagnosis of malignant tumors.
Index test:Detection rate, SUVmax, SUVmean, MTV/FTV, TLG/TLF, TBRliver and TBRblood

Sponsors

The First Affiliated Hospital of Dalian Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Patients with suspected or confirmed malignant tumors undergo PET/CT and/or PET/MRI for the purposes of diagnosis and differential diagnosis, searching for primary lesions, clinical staging, assessment of prognosis, and evaluation of therapeutic efficacy.

Exclusion criteria

Exclusion criteria: (1) Pregnant and lactating women. (2) Patients with poor autonomy (e.g., inability to lie down), severe claustrophobia, critically ill patients requiring life support, etc., who are unable to cooperate with the examination. (3) Patients with other conditions that make them unsuitable for the examination.

Design outcomes

Primary

MeasureTime frame
PET/CT imaging;

Secondary

MeasureTime frame
Detection rate;SUVmax (maximum standard uptake volume);SUVmean mean standard uptake volume;TLG (total lesion glycolysis) /TLF (total lesion FAP expression) ;MTV (metabolic tumor volume)/ FTV(FAP expression tumor volume) ;TBR (tumor-to-background ratio) ;

Countries

China

Contacts

Public ContactHongna Zheng

The First Affiliated Hospital of Dalian Medical University

zhenghongna@126.com+86 180 9887 6906

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026